Rising demand for minimally invasive surgical procedures due to their numerous benefits such as shorter recovery time, reduced hospital stay, and lower risk of complications is a major growth driver for the minimally invasive surgical instrument market.
Technological advancements in minimally invasive surgical instruments, such as the development of robotic-assisted surgical systems, are also driving market growth by enabling more precise and less invasive procedures.
Increasing adoption of minimally invasive surgeries across various medical specialties, including cardiology, gynecology, and orthopedics, is creating new opportunities for growth in the market.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Product, Surgery Type, End-Use |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Medtronic, Siemens Healthineer AG, Ethicon, (Johnson & Johnson), GE Healthcare, Intutive Surgical, Nuvasive, Zimmer Biomet, Stryker, Boston Scientific, B. Braun Melsungen AG, CONMED, Smith & Nephew Plc., Becton, Dickinson and Company |
High cost of minimally invasive surgical instruments and procedures is a major restraint for market growth, particularly in developing countries where healthcare infrastructure and funding may be limited.
Limited access to specialized training and expertise in minimally invasive surgical techniques is another key restraint that could hinder market growth, as healthcare providers may be reluctant to adopt these techniques without proper training and support.